Advertisement

Topics

BioRexis Pharmaceutical Corporation Company Profile

04:07 EDT 25th June 2018 | BioPortfolio

BioRexis™ develops and produces novel biopharmaceuticals with superior pharmacology using efficient manufacturing systems. Many biopharmaceuticals face difficulties in development and commercialization due to pharmacological issues. For example, many peptides that are currently approved or in development have a very short half-life, requiring both high and frequent dosing. Unwanted side effects from high peak levels can limit therapeutic benefit, and frequent trough low levels may narrow application of the particular product. High dosing per patient also places a further burden on already limited manufacturing capacity, driving up the cost of treatment, as in the case of monoclonal antibodies and other high-priced biopharmaceuticals.

Location

3400 Horizon Drive
King of Prussia
Pennsylvania
19406
United States of America

Contact

Phone: (610) 313-4000
Fax: (610) 313-4039
Email: info@biorexis.com.


News Articles [353 Associated News Articles listed on BioPortfolio]

Orion Corporation: Transfer of 112,961 own B shares on 1 March 2018

ORION CORPORATION         STOCK EXCHANGE RELEASE         1 MARCH 2018   at 19.10 EET             Orion Corporation: Transfer of ...

Orion Corporation: Managers' transactions - Ari Lehtoranta

ORION CORPORATION         MANAGERS' TRANSACTIONS 3 MAY 2018 at 11.40 EETS Orion Corporation: Managers' transactions - Ari Lehtoranta Orion Corporation has received the...

Orion Corporation: Managers' transactions - Liisa Hurme

ORION CORPORATION         MANAGERS' TRANSACTIONS 2nd of March 2018 at 9.45 EET Orion Corporation: Managers' transactions - Liisa Hurme Orion Corporation has received...

Orion has completed the sale of Orion Diagnostica business division

ORION CORPORATION         PRESS RELEASE                30 April 2018 at 12.15 p.m. Orion has completed the sale of Orion Diagnostica business division Orion C...

Orion Corporation: Managers' transactions - Timo Maasilta

ORION CORPORATION         MANAGERS' TRANSACTIONS 3 MAY 2018 at 11.40 EETS Orion Corporation: Managers' transactions - Timo Maasilta Orion Corporation has received the ...

Orion Corporation: Managers' transactions - Mikael Silvennoinen

ORION CORPORATION         MANAGERS' TRANSACTIONS 3 MAY 2018 at 11.40 EEST              Orion Corporation: Managers' transactions - Mikael Silvennoinen Orio...

Orion Corporation: Managers' transactions - Sirpa Jalkanen

ORION CORPORATION         MANAGERS' TRANSACTIONS 3 MAY 2018 at 11.40 EETS Orion Corporation: Managers' transactions - Sirpa Jalkanen Orion Corporation has received the ...

Orion Corporation: Managers' transactions - Eija Ronkainen

ORION CORPORATION         MANAGERS' TRANSACTIONS 3 MAY 2018 at 11.40 EEST Orion Corporation: Managers' transactions - Eija Ronkainen Orion Corporation has received...

PubMed Articles [469 Associated PubMed Articles listed on BioPortfolio]

Pharmaceutical cocrystals as an opportunity to modify drug properties: From the idea to application. A review.

The properties of many drugs which have been available on the pharmaceutical market for a long time still need to be improved. Cocrystals are the solid state drug modification which can improve such p...

Total Health-related Costs Due to Absenteeism, Presenteeism, and Medical and Pharmaceutical Expenses in Japanese Employers.

This study aimed to examine a detailed breakdown of costs (absenteeism, presenteeism, and medical/pharmaceutical expenses), of the employees in four pharmaceutical companies in Japan.

Pharmaceutical Cocrystals: New Solid Phase Modification Approaches for the Formulation of APIs.

Cocrystals can be used as an alternative approach based on crystal engineering to enhance specific physicochemical and biopharmaceutical properties of active pharmaceutical ingredients (APIs) when the...

Applications of various analytical techniques in quality control of pharmaceutical excipients.

Although excipients are pharmacologically inert substances, still they are integral and significant ingredients of a pharmaceutical formulation. Their amount and concentration level along with the act...

The source and diversion of pharmaceutical drugs for non-medical use: A systematic review and meta-analysis.

The non-medical use (NMU) of pharmaceutical drugs is an increasing public health concern. This systematic review consolidates current knowledge about how pharmaceutical drugs are obtained for NMU and ...

Clinical Trials [300 Associated Clinical Trials listed on BioPortfolio]

Pharmaceutical Care for Asthma Control Improvement (PHARMACI)-Study

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for asthma patients.

Pharmaceutical Care for Diabetes Type 2 Patients: a Randomised Controlled Trial

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for diabetes type 2 patients. Patients will be randomly allocated to th...

Improving Compliance Among Elderly Polypharmacy Users Through Community Pharmacy Based Pharmaceutical Care Program

The aim of the project is to evaluate effectiveness of a multidimensional pharmaceutical care plan in improving compliance among elderly polypharmacy users at community pharmacy settings. ...

Impact of Collaborative Pharmaceutical Care on Hospital Admission Drug Prescriptions for Patients 65 Years of Age and Older

The primary objective of this study is to evaluate the impact of the implementation of collaborative pharmaceutical care on drug support at admission for patients 65 years of age and older...

Individualized Pharmaceutical-care in Outpatients With Cancer Pain

The purpose of the study is to investigate the impact of pharmaceutical care on cancer pain treatment for opioid-tolerant outpatients

Companies [1216 Associated Companies listed on BioPortfolio]

BioRexis Pharmaceutical Corporation

BioRexis™ develops and produces novel biopharmaceuticals with superior pharmacology using efficient manufacturing systems. Many biopharmaceuticals face difficulties in development and commercializat...

Toshiba Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultr...

Bruker Daltonics

Bruker Corporation is a leading provider of high-performance scientific instruments and solutions for molecular and materials research, as well as for industrial and applied analy...

Oriola

Oriola is a part of Oriola-KD Corporation that was formed as a result of demerge of Orion Corporation on 1st of July 2006. The company is listed in the Helsinki Stock Exchange since 3rd of July 2006. ...

One Eleven Corporation

One Eleven Corporation is a leader in the development of digital solutions for healthcare professionals. For the past 16 years, One Eleven has proven that healthcare professionals...

More Information about "BioRexis Pharmaceutical Corporation" on BioPortfolio

We have published hundreds of BioRexis Pharmaceutical Corporation news stories on BioPortfolio along with dozens of BioRexis Pharmaceutical Corporation Clinical Trials and PubMed Articles about BioRexis Pharmaceutical Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioRexis Pharmaceutical Corporation Companies in our database. You can also find out about relevant BioRexis Pharmaceutical Corporation Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record